MedPath

SGS-742

Generic Name
SGS-742
Drug Type
Small Molecule
Chemical Formula
C7H18NO2P
CAS Number
123690-78-8
Unique Ingredient Identifier
GBZ5UC0RME

Overview

SGS-742 has been used in trials studying the treatment of Seizures and Metabolic Disease.

Background

SGS-742 has been used in trials studying the treatment of Seizures and Metabolic Disease.

Indication

Investigated for use/treatment in alzheimer's disease, attention deficit/hyperactivity disorder (ADHD), memory loss, and schizophrenia and schizoaffective disorders.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath